Myosin IF inhibitors belong to a distinct chemical class of compounds designed to modulate cellular processes by specifically targeting myosin IF, an essential protein involved in various cellular functions. Myosins are a diverse family of motor proteins that play pivotal roles in intracellular transport, cell motility, and muscle contraction. Among these, myosin IF is a unique isoform that stands out due to its role in governing intracellular dynamics and cellular structure. Myosin IF inhibitors are synthesized with the primary aim of altering the functionality of myosin IF, thus influencing cellular processes in a controlled manner.
These inhibitors are typically small molecules that exert their effects by binding to myosin IF, either directly or indirectly, disrupting its normal function. Myosin IF is an essential component of the cytoskeleton, a dynamic network of protein filaments within cells that provides structural support, enables cell movement, and facilitates intracellular transport. Consequently, when myosin IF inhibitors interact with this protein, they can induce alterations in cell shape, motility, and transport processes. By selectively targeting myosin IF, these inhibitors offer a tool for researchers to investigate the intricate mechanisms governing cellular dynamics and cytoskeletal organization. Moreover, they have the potential to shed light on fundamental cellular processes, ultimately advancing our understanding of cell biology and potentially opening up avenues for further research in various fields.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin is a small molecule inhibitor that specifically targets non-muscle myosin II. It is widely used in cell biology to study cell motility and contraction. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is a myosin light chain kinase (MLCK) inhibitor that prevents the phosphorylation of myosin light chains, thus inhibiting smooth muscle contraction. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a myosin II ATPase inhibitor and a calpain inhibitor. It can inhibit both myosin activity and calpain-mediated proteolysis. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a specific inhibitor of Rho-associated protein kinase (ROCK), which indirectly affects myosin phosphorylation and contraction by inhibiting the downstream signaling pathway. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker that indirectly inhibits myosin-mediated muscle contraction by reducing the availability of calcium ions. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A is a toxin that disrupts actin filaments, indirectly affecting myosin's ability to interact with actin in muscle cells. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide is a peptide toxin that stabilizes actin filaments, which can lead to myosin inhibition by interfering with actin-myosin interactions. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Similar to jasplakinolide, cytochalasin D is a fungal metabolite that disrupts actin filaments, thereby indirectly affecting myosin function. | ||||||